» Articles » PMID: 18443637

Opioid Pharmacology

Overview
Journal Pain Physician
Date 2008 Jun 17
PMID 18443637
Citations 266
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mu agonists have been an important component of pain treatment for thousands of years. The usual pharmacokinetic parameters (half-life, clearance, volume of distribution) of opioids have been known for some time. However, the metabolism has, until recently, been poorly understood, and there has been recent interest in the role of metabolites in modifying the pharmacodynamic response in patients, in both analgesia and adverse effects. A number of opioids are available for clinical use, including morphine, hydromorphone, levorphanol, oxycodone, and fentanyl. Advantages and disadvantages of various opioids in the management of chronic pain are discussed.

Objective: This review looks at the structure, chemistry, and metabolism of opioids in an effort to better understand the side effects, drug interactions, and the individual responses of patients receiving opioids for the treatment of intractable pain.

Conclusion: Mu receptor agonists and agonist-antagonists have been used throughout recent medical history for the control of pain and for the treatment of opiate induced side effects and even opiate withdrawal syndromes.

Citing Articles

Impact of opioid abuse on oral health: a retrospective cohort study.

Smeda M, Knogl C, Muller K, Stahl M, Buchalla W, Keim L Front Oral Health. 2025; 6:1483406.

PMID: 40061255 PMC: 11885281. DOI: 10.3389/froh.2025.1483406.


Peptide hydrogel-drug conjugates for tailored disease treatment.

Cauwenbergh T, Ballet S, Martin C Mater Today Bio. 2025; 31:101423.

PMID: 39944533 PMC: 11815290. DOI: 10.1016/j.mtbio.2024.101423.


Opioid receptor signaling throughout ontogeny: Shaping neural and behavioral trajectories.

Spodnick M, McElderry S, Diaz M Neurosci Biobehav Rev. 2025; 170:106033.

PMID: 39894419 PMC: 11851333. DOI: 10.1016/j.neubiorev.2025.106033.


Visceral Pain in Preterm Infants with Necrotizing Enterocolitis: Underlying Mechanisms and Implications for Treatment.

Ten Barge J, van den Bosch G, Slater R, van den Hoogen N, Reiss I, Simons S Paediatr Drugs. 2025; 27(2):201-220.

PMID: 39752054 PMC: 11829917. DOI: 10.1007/s40272-024-00676-0.


Characterizing and responding to stimulant overdoses: Findings from a mixed methods study of people who use cocaine and other stimulants in New England.

Hughto J, Kelly P, Vento S, Pletta D, Noh M, Silcox J Drug Alcohol Depend. 2024; 266:112501.

PMID: 39608288 PMC: 11685032. DOI: 10.1016/j.drugalcdep.2024.112501.